Related Experiment Video
Updated: Jun 24, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Fungal vaccines and adjuvants: a tool to reveal the interaction between host and fungi
1Laboratory of Anti-Infection and Immunity, College of Integrated Chinese and Western Medicine (College of Life Science), Anhui University of Chinese Medicine, Zhijing Building, 350 Longzihu Road, Xinzhan District, Hefei, 230012, Anhui, People's Republic of China.
Abstract:
Fungal infections are incurring high risks in a range from superficial mucosal discomforts (such as oropharyngeal candidiasis and vulvovaginal candidiasis) to disseminated life-threatening diseases (such as invasive pulmonary aspergillosis and cryptococcal meningitis) and becoming a global health problem in especially immunodeficient population. The major obstacle to conquer fungal harassment lies in the presence of increasing resistance to conventional antifungal agents used in newly clinically isolated strains. Although recombinant cytokines and mono-/poly-clonal antibodies are added into antifungal armamentarium, more effective antimycotic drugs are exceedingly demanded. It is comforting that the development of fungal vaccines and adjuvants opens up a window to brighten the prospective way in the diagnosis, prevention and treatment of fungal assaults. In this review, we focus on the progression of several major fungal vaccines devised for the control of Candida spp., Aspergillus spp., Cryptococcus spp., Coccidioides spp., Paracoccidioides spp., Blastomyces spp., Histoplasma spp., Pneumocystis spp. as well as the adjuvants adopted. We then expound the interaction between fungal vaccines/adjuvants and host innate (macrophages, dendritic cells, neutrophils), humoral (IgG, IgM and IgA) and cellular (Th1, Th2, Th17 and Tc17) immune responses which generally experience immune recognition of pattern recognition receptors, activation of immune cells, and clearance of invaded fungi. Furthermore, we anticipate an in-depth understanding of immunomodulatory properties of univalent and multivalent vaccines against diverse opportunistic fungi, providing helpful information in the design of novel fungal vaccines and adjuvants.
Insights
Fungal infections pose a global health threat, especially to immunocompromised individuals. This review explores advances in fungal vaccines and adjuvants to combat drug-resistant fungal infections and enhance immune responses.
Area of Science:
- Mycology
- Immunology
- Vaccinology
Background:
- Fungal infections present a growing global health challenge, particularly for immunocompromised populations, ranging from superficial to life-threatening disseminated diseases.
- Increasing resistance to conventional antifungal agents necessitates novel therapeutic and prophylactic strategies.
- Current antifungal armamentarium includes recombinant cytokines and antibodies, but more effective treatments are urgently needed.
Purpose of the Study:
- To review the progress of major fungal vaccines and adjuvants for controlling various fungal pathogens.
- To elucidate the interactions between fungal vaccines/adjuvants and host immune responses, including innate, humoral, and cellular immunity.
- To provide insights into the immunomodulatory properties of fungal vaccines for designing novel strategies.
Main Methods:
- Literature review focusing on fungal vaccines and adjuvants.
- Analysis of immune responses elicited by vaccines, including pattern recognition receptor activation, immune cell activation, and fungal clearance.
- Examination of immunomodulatory properties of univalent and multivalent fungal vaccines.
Main Results:
- Development of fungal vaccines and adjuvants offers a promising avenue for diagnosis, prevention, and treatment of fungal infections.
- Vaccines/adjuvants engage innate (macrophages, dendritic cells, neutrophils), humoral (IgG, IgM, IgA), and cellular (Th1, Th2, Th17, Tc17) immune pathways.
- Understanding vaccine-induced immunomodulation aids in designing effective strategies against diverse opportunistic fungi.
Conclusions:
- Fungal vaccines and adjuvants are critical for addressing the global challenge of drug-resistant fungal infections.
- Further research into vaccine-host interactions will refine the development of next-generation antifungal therapies.
- Novel vaccine designs hold significant potential for improving the management of fungal diseases in vulnerable populations.
More Related Videos
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
Related Concept Videos
Vaccinations
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cell-mediated Immune Responses
Cross-reactivity
Tumor Immunotherapy